Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Kuo, Y ^a   Ren, S ^a   Lao, U ^b   Edgar, B A ^c   Wang, T ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

APG 1; HCS70ab; HSP110; HSP40; Neurodegeneration; PolyQ

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK COGNATE PROTEIN 70CB; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 90; POLYGLUTAMINE; PROTEIN DNAJ; PROTEIN DNAJ 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL FUNCTION; COMPOUND EYE; CONTROLLED STUDY; CYTOTOXICITY; FRUIT FLY MODEL; GENE EXPRESSION; GENE INTERACTION; GENE REPRESSION; HUNTINGTON CHOREA; IN VIVO STUDY; NERVE CELL DEGENERATION; NERVE DEGENERATION; NONHUMAN; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; RETINA DEGENERATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL DEATH; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HSP110 HEAT-SHOCK PROTEINS; HSP40 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HUNTINGTON DISEASE; IMMUNOPRECIPITATION; NERVE DEGENERATION; PEPTIDES; PROTEIN BINDING; RETINA;

EID: 84887473021     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.351     Document Type: Article

References (57)

1. Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 2009; 78: 959-991.
2. Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: Mechanisms and common principles. Nat Rev Genet 2005; 6: 743-755.
3. Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005; 6: 11-22.
4. Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011; 475: 324-332.
5. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006; 125: 443-451.
6. Vabulas RM, Raychaudhuri S, Hayer-Hartl M, Hartl FU. Protein folding in the cytoplasm and the heat shock response. Cold Spring Harb Perspect Biol 2010; 2: A004390.
7. Fujimoto M, Takaki E, Hayashi T, Kitaura Y, Tanaka Y, Inouye S et al. Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem 2005; 280: 34908-34916.
8. Hayashida N, Fujimoto M, Tan K, Prakasam R, Shinkawa T, Li L et al. Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT. EMBO J 2010; 29: 3459-3469.
9. Kampinga HH, Craig EA. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 2010; 11: 579-592.
10. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 2000; 408: 101-106.
11. Kazemi-Esfarjani P, Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 2000; 287: 1837-1840.
12. Bilen J, Bonini NM. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 2007; 3: 1950-1964.
13. Chuang JZ, Zhou H, Zhu M, Li SH, Li XJ, Sung CH. Characterization of a brain-enriched chaperone, MRJ, that inhibits Huntingtin aggregation and toxicity independently. J Biol Chem 2002; 277: 19831-19838.
14. Rujano MA, Kampinga HH, Salomons FA. Modulation of polyglutamine inclusion formation by the Hsp70 chaperone machine. Exp Cell Res 2007; 313: 3568-3578.
15. Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N et al. A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Mol Cell 2010; 7: 355-369.
16. Kobayashi Y, Kume A, Li M, Doyu M, Hata M, Ohtsuka K et al. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol Chem 2000; 275: 8772-8778.
17. Jana NR, Tanaka M, Wang G, Nukina N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-Terminal huntingtin: Their role in suppression of aggregation and cellular toxicity. Hum Mol Genet 2000; 9: 2009-2018.
18. Oh HJ, Chen X, Subjeck Jr. Hsp110 protects heat-denatured proteins and confers cellular thermoresistance. J Biol Chem 1997; 272: 31636-31640.
19. Goeckeler JL, Stephens A, Lee P, Caplan AJ, Brodsky JL. Overexpression of yeast Hsp110 homolog Sse1p suppresses ydj1-151 thermosensitivity and restores Hsp90-dependent activity. Mol Biol Cell 2002; 13: 2760-2770.
20. Shaner L, Trott A, Goeckeler JL, Brodsky JL, Morano KA. The function of the yeast molecular chaperone Sse1 is mechanistically distinct from the closely related hsp70 family. J Biol Chem 2004; 279: 21992-22001.
21. Yam AY, Albanese V, Lin HT, Frydman J. Hsp110 cooperates with different cytosolic HSP70 systems in a pathway for de novo folding. J Biol Chem 2005; 280: 41252-41261.
22. Shaner L, Wegele H, Buchner J, Morano KA. The yeast Hsp110 Sse1 functionally interacts with the Hsp70 chaperones Ssa and Ssb. J Biol Chem 2005; 280: 41262-41269.
23. Raviol H, Sadlish H, Rodriguez F, Mayer M.P, Bukau B. Chaperone network in the yeast cytosol: Hsp110 is revealed as an Hsp70 nucleotide exchange factor. EMBO J 2006; 25: 2510-2518.
24. Dragovic Z, Broadley SA, Shomura Y, Bracher A, Hartl FU. Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s. EMBO J 2006; 25: 2519-2528.
25. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci USA 2009; 106: 1392-1397.
26. Yamashita H, Kawamata J, Okawa K, Kanki R, Nakamizo T, Hatayama T et al. Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: Clues to a possible strategy for treating ALS. J Neurochem 2007; 102: 1497-1505.
27. Saxena A, Banasavadi-Siddegowda YK, Fan Y, Bhattacharya S, Roy G, Giovannucci DR et al. Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels. J Biol Chem 2012; 287: 19158-19170.
28. Eroglu B, Moskophidis D, Mivechi NF. Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta. Mol Cell Biol 2010; 30: 4626-4643.
29. Jaiswal M, Sandoval H, Zhang K, Bayat V, Bellen HJ. Probing mechanisms that underlie human neurodegenerative disease in Drosophila. Annu Rev Genet 2012; 46: 371-396.
30. Yu Z, Bonini NM. Modeling human trinucleotide repeat diseases in Drosophila. Int Rev Neurobiol 2011; 99: 191-212.
31. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 1998; 19: 148-154.
32. Vos MJ, Hageman J, Carra S, Kampinga HH. Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 2008; 47: 7001-7011.
33. Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL, Bonini NM. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 1999; 23: 425-428.
34. Chan HY, Warrick JM, Gray-Board GL, Paulson HL, Bonini NM. Mechanisms of chaperone suppression of polyglutamine disease: Selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet 2000; 9: 2811-2820.
35. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993; 118: 401-415.
36. Gong WJ, Golic KG. Genomic deletions of the Drosophila melanogaster Hsp70 genes. Genetics 2004; 168: 1467-1476.
37. Fayazi Z, Ghosh S, Marion S, Bao X, Shero M, Kazemi-Esfarjani P. A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation. Neurobiol Dis 2006; 24: 226-244.
38. Ni JQ, Zhou R, Czech B, Liu LP, Holderbaum L, Yang-Zhou D et al. A genome-scale shRNA resource for transgenic RNAi in Drosophila. Nat Methods 2011; 8: 405-407.
39. Zhang S, Binari R, Zhou R, Perrimon N. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 2009; 184: 1165-1179.
40. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW et al. Polyglutamineexpanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 1998; 21: 633-642.
41. Hageman J, Kampinga HH. Computational analysis of the human HSPH/HSPA/DNAJ family and cloning of a human HSPH/HSPA/DNAJ expression library. Cell Stress Chaperones 2009; 14: 1-21.
42. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009; 14: 105-111.
43. Kaneko Y, Nishiyama H, Nonoguchi K, Higashitsuji H, Kishishita M, Fujita J. A novel hsp110-related gene, apg-1, that is abundantly expressed in the testis responds to a low temperature heat shock rather than the traditional elevated temperatures. J Biol Chem 1997; 272: 2640-2645.
44. Yasuda K, Nakai A, Hatayama T, Nagata K. Cloning and expression of murine high molecular mass heat shock proteins, HSP105. J Biol Chem 1995; 270: 29718-29723.
45. Zijlstra MP, Rujano MA, Van Waarde MA, Vis E, Brunt ER, Kampinga HH. Levels of DNAJB family members (HSP40) correlate with disease onset in patients with spinocerebellar ataxia type 3. Eur J Neurosci 2010; 32: 760-770.
46. Howarth JL, Kelly S, Keasey MP, Glover CP, Lee YB, Mitrophanous K et al. Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. Mol Ther 2007; 15: 1100-1105.
47. Bailey CK, Andriola IF, Kampinga HH, Merry DE. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet 2002; 11: 515-523.
48. Sadlish H, Rampelt H, Shorter J, Wegrzyn RD, Andreasson C, Lindquist S et al. Hsp110 chaperones regulate prion formation and propagation in S. cerevisiae by two discrete activities. PLoS One 2008; 3: E1763.
49. Hrizo SL, Gusarova V, Habiel DM, Goeckeler JL, Fisher EA, Brodsky JL. The Hsp110 molecular chaperone stabilizes apolipoprotein B from endoplasmic reticulum-Associated degradation (ERAD). J Biol Chem 2007; 282: 32665-32675.
50. Hartl FU, Hayer-Hartl M. Converging concepts of protein folding in vitro and in vivo. Nat Struct Mol Biol 2009; 16: 574-581.
51. Shorter J. The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS One 2011; 6: E26319.
52. Rampelt H, Kirstein-Miles J, Nillegoda NB, Chi K, Scholz SR, Morimoto RI et al. Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J 2012; 31: 4221-4235.
53. Carra S, Sivilotti M, Chavez Zobel AT, Lambert H, Landry J. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet 2005; 14: 1659-1669.
54. Ishihara K, Yamagishi N, Saito Y, Adachi H, Kobayashi Y, Sobue G et al. Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity. J Biol Chem 2003; 278: 25143-25150.
55. Wang T, Lao U, Edgar BA. TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J Cell Biol 2009; 186: 703-711.
56. Wang T, Blumhagen R, Lao U, Kuo Y, Edgar BA. LST8 regulates cell growth via targetof-rapamycin complex 2 (TORC2). Mol Cell Biol 2012; 32: 2203-2213.
57. Marchler G, Wu C. Modulation of Drosophila heat shock transcription factor activity by the molecular chaperone DROJ1. EMBO J 2001; 20: 499-509.